Summary
The objective of this study is to address the public health policy question “What will be the impact of male vaccination strategies on the long-term burden of HPV infections and associated precancer and cancer among men who have sex with men (MSM)?”
Specific aims: For the population of young MSM (aged 16-30) in Vancouver, Toronto, and Montreal, our aims are to: (a) estimate prevalence of type-specific HPV infection in the anal and oral tracts at the onset of vaccine program implementation; (b) estimate expected uptake of HPV vaccine; (c) identify characteristics of males not likely to be immunized; and, (d) predict the population-level impact and cost-effectiveness of current and alternative HPV vaccination strategies.
Funded By
- Canadian Institutes of Health Research
Principal Investigator
- Ann Burchell
Co-Investigators
- Longdi Fu
- Wanrudee Isaranuwatchai
- Ioana Nicolau
- Anna Yeung
KTP Project Staff
- Sujata Mishra